Exactis Innovation is standardizing its sequencing labs as it aims to quickly match at-risk cancer patients with clinical trials through its longitudinal, biopsy-led registry.
Original Article: A molecular match: Exactis using Thermo NGS tech to profile patient samples, speed trial matching